In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 15th, 2008 | 16 | Yes |
Popular Name: Harmine Harmine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 343-27-1 , 442-51-3 , CAS# 442-51-3 , [343-27-1] , [442-51-3]
343-27-1; Harmine hydrochloride; Prestwick_254
7-Methoxy-1-methyl-9H-beta-carboline
7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole
7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole hydrochloride
Harmine [442-51-3]; (Banisterine)
Harmine hydrochloride dehydrate [343-27-1]
HARMINE HYDROCHLORIDE DIHYDRATE
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.63 | 5.25 | -32.65 | 2 | 3 | 1 | 39 | 213.26 | 1 | ↓ |
Hi High (pH 8-9.5) | 2.63 | 4.83 | -7.3 | 1 | 3 | 0 | 38 | 212.252 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_source | Alkaloid from Peganum harmala, several Banisteriopsis spp., Passiflora edulis and several other spp. (Zygophyllaceae, Malphigiaceae, Passifloraceae) | ZereneX Building Blocks |
APPEARANCE | . | Indofine Natural Products |
M.P | 260-262 C | Indofine Natural Products |
Mp [°C] | 262 - 264 | Acros Organics |
M.P | 262-264 ° | Indofine Natural Products |
Melting_Point | 262-266? | Alfa-Aesar |
Melting_Point | 262-266° | Alfa-Aesar |
M.P | 264-266C | Indofine Natural Products |
ALOGPS_SOLUBILITY | 6.13e-02 g/l | DrugBank-experimental |
Purity | 95% | Fluorochem |
Purity | 98% | Fluorochem |
biological_use | Active against gram-positive bacteria and fungi | IBScreen Bioactives |
biological_use | Antiparkinsonian agent | IBScreen Bioactives IBScreen Bioactives |
Therapy | antiparkinsonian, CNS stimulant | SMDC MicroSource |
mechanism | CNS stimulant | IBScreen Bioactives IBScreen Bioactives |
UniProt Database Links | DYRK2_HUMAN | ChEBI |
PUBCHEM_PATENT_ID | EP0034521A1; EP0041764A1; EP0322082A1; EP0331391A1; EP0355575A2; EP0355575B1; EP0573498B1; EP0804200A1; EP1032423A1; US4336459; US4382935; US4499096; US4587243; US4857523; US4885154; US5169868; US5196164; US5256533; US5298220; US5304379; US5405782; US5466 | IBM Patent Data |
SOLUBILITY | From Peganum harmala seeds | Indofine Natural Products |
H phrase | H302: Harmful if swallowed | Acros Organics |
H phrase | H302: Harmful if swallowed; H332: Harmful if inhaled; H312: Harmful in contact with skin | Acros Organics |
mechanism | MAO-A inhibitor | IBScreen Bioactives |
APPEARANCE | Off-White Solid | Indofine Natural Products |
P phrase | P280: Wear protective gloves/protective clothing/eye protection/face protection | Acros Organics |
P phrase | P280: Wear protective gloves/protective clothing/eye protection/face protection; P302 + P352: IF ON SKIN: Wash with plenty of soap and water; P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell; P304 + P340: IF INHALED: R | Acros Organics |
R phrase | R20/21/22: Harmful by inhalation, in contact with skin and if swallowed. | Acros Organics |
S phrase | S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. | Acros Organics |
S phrase | S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S37/39: Wear suitable gloves and eye/face protection. | Acros Organics |
Hazard | XN: Harmful | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT2A-2-E | Serotonin 2a (5-HT2a) Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 7790 | 0.45 | Binding ≤ 10μM |
5HT2C-1-E | Serotonin 2c (5-HT2c) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 9340 | 0.44 | Binding ≤ 10μM |
5HT6R-2-E | Serotonin 6 (5-HT6) Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1480 | 0.51 | Binding ≤ 10μM |
5HT7R-2-E | Serotonin 7 (5-HT7) Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 5500 | 0.46 | Binding ≤ 10μM |
ADA2A-4-E | Alpha-2a Adrenergic Receptor (cluster #4 Of 4), Eukaryotic | Eukaryotes | 2540 | 0.49 | Binding ≤ 10μM |
ADA2B-1-E | Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1130 | 0.52 | Binding ≤ 10μM |
ADA2C-4-E | Alpha-2c Adrenergic Receptor (cluster #4 Of 4), Eukaryotic | Eukaryotes | 810 | 0.53 | Binding ≤ 10μM |
AOFA-4-E | Monoamine Oxidase A (cluster #4 Of 8), Eukaryotic | Eukaryotes | 5 | 0.73 | Binding ≤ 10μM |
AOFB-6-E | Monoamine Oxidase B (cluster #6 Of 8), Eukaryotic | Eukaryotes | 49 | 0.64 | Binding ≤ 10μM |
DYR1A-1-E | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1A (cluster #1 Of 3), Eukaryotic | Eukaryotes | 80 | 0.62 | Binding ≤ 10μM |
DYRK2-1-E | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 900 | 0.53 | Binding ≤ 10μM |
DYRK3-1-E | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 800 | 0.53 | Binding ≤ 10μM |
KC1D-1-E | Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.51 | Binding ≤ 10μM |
NISCH-3-E | Nischarin (cluster #3 Of 4), Eukaryotic | Eukaryotes | 49 | 0.64 | Binding ≤ 10μM |
PIM3-1-E | Serine/threonine-protein Kinase PIM3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4300 | 0.47 | Binding ≤ 10μM |
SC6A2-2-E | Norepinephrine Transporter (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3260 | 0.48 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 50 | 0.64 | Functional ≤ 10μM |
Z50607-3-O | Human Immunodeficiency Virus 1 (cluster #3 Of 10), Other | Other | 520 | 0.55 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 810 | 0.53 | Binding ≤ 1μM |
DYR1A_HUMAN | Q13627 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 1A, Human | 80 | 0.62 | Binding ≤ 1μM |
DYRK2_HUMAN | Q92630 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 2, Human | 900 | 0.53 | Binding ≤ 1μM |
DYRK3_HUMAN | O43781 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 3, Human | 800 | 0.53 | Binding ≤ 1μM |
AOFA_HUMAN | P21397 | Monoamine Oxidase A, Human | 16.9 | 0.68 | Binding ≤ 1μM |
AOFA_RAT | P21396 | Monoamine Oxidase A, Rat | 49 | 0.64 | Binding ≤ 1μM |
AOFB_RAT | P19643 | Monoamine Oxidase B, Rat | 49 | 0.64 | Binding ≤ 1μM |
NISCH_HUMAN | Q9Y2I1 | Nischarin, Human | 22 | 0.67 | Binding ≤ 1μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 2540 | 0.49 | Binding ≤ 10μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 1130 | 0.52 | Binding ≤ 10μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 810 | 0.53 | Binding ≤ 10μM |
KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 1500 | 0.51 | Binding ≤ 10μM |
DYR1A_HUMAN | Q13627 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 1A, Human | 80 | 0.62 | Binding ≤ 10μM |
DYRK2_HUMAN | Q92630 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 2, Human | 900 | 0.53 | Binding ≤ 10μM |
DYRK3_HUMAN | O43781 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 3, Human | 800 | 0.53 | Binding ≤ 10μM |
AOFA_HUMAN | P21397 | Monoamine Oxidase A, Human | 16.9 | 0.68 | Binding ≤ 10μM |
AOFA_RAT | P21396 | Monoamine Oxidase A, Rat | 49 | 0.64 | Binding ≤ 10μM |
AOFB_RAT | P19643 | Monoamine Oxidase B, Rat | 49 | 0.64 | Binding ≤ 10μM |
NISCH_HUMAN | Q9Y2I1 | Nischarin, Human | 22 | 0.67 | Binding ≤ 10μM |
SC6A2_HUMAN | P23975 | Norepinephrine Transporter, Human | 3260 | 0.48 | Binding ≤ 10μM |
PIM3_HUMAN | Q86V86 | Serine/threonine-protein Kinase PIM3, Human | 4300 | 0.47 | Binding ≤ 10μM |
5HT2A_RAT | P14842 | Serotonin 2a (5-HT2a) Receptor, Rat | 7790 | 0.45 | Binding ≤ 10μM |
5HT2C_HUMAN | P28335 | Serotonin 2c (5-HT2c) Receptor, Human | 9340 | 0.44 | Binding ≤ 10μM |
5HT6R_HUMAN | P50406 | Serotonin 6 (5-HT6) Receptor, Human | 1480 | 0.51 | Binding ≤ 10μM |
5HT7R_HUMAN | P34969 | Serotonin 7 (5-HT7) Receptor, Human | 5500 | 0.46 | Binding ≤ 10μM |
Z50607 | Z50607 | Human Immunodeficiency Virus 1 | 520 | 0.55 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 182.4 | 0.59 | Functional ≤ 10μM |
Description | Species |
---|---|
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
Circadian Clock | |
Enzymatic degradation of dopamine by COMT | |
Enzymatic degradation of Dopamine by monoamine oxidase | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (s) signalling events | |
G alpha (z) signalling events | |
G0 and Early G1 | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
Metabolism of serotonin | |
Monoamines are oxidized to aldehydes by MAOA and MAOB, producing NH3 and H2O2 | |
Na+/Cl- dependent neurotransmitter transporters | |
Norepinephrine Neurotransmitter Release Cycle | |
Recruitment of mitotic centrosome proteins and complexes | |
Regulation of PLK1 Activity at G2/M Transition | |
Serotonin receptors |
No pre-computed analogs available. Try a structural similarity search.